Y. Hagihara

Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.

K. Tominaga, Toshio Watanabe, Y. Fujiwara, 2014, Journal of Crohn's & colitis.